Brian Abrahams
Stock Analyst at RBC Capital
(2.40)
# 2,607
Out of 5,084 analysts
447
Total ratings
46.28%
Success rate
-1.72%
Average return
Main Sectors:
Stocks Rated by Brian Abrahams
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SION Sionna Therapeutics | Downgrades: Underperform | $24 | $41.11 | -41.62% | 2 | Dec 1, 2025 | |
| PTCT PTC Therapeutics | Downgrades: Sector Perform | $82 → $91 | $78.08 | +16.55% | 23 | Dec 1, 2025 | |
| NMRA Neumora Therapeutics | Upgrades: Outperform | $4 → $7 | $2.32 | +201.72% | 7 | Dec 1, 2025 | |
| CTNM Contineum Therapeutics | Maintains: Outperform | $25 → $22 | $11.29 | +94.86% | 6 | Nov 21, 2025 | |
| AARD Aardvark Therapeutics | Maintains: Outperform | $19 → $18 | $12.33 | +46.04% | 5 | Nov 14, 2025 | |
| CRBP Corbus Pharmaceuticals Holdings | Maintains: Outperform | $55 → $53 | $10.63 | +398.59% | 9 | Nov 13, 2025 | |
| ATYR aTyr Pharma | Maintains: Sector Perform | $1.5 → $1 | $0.84 | +19.16% | 2 | Nov 7, 2025 | |
| PRTA Prothena Corporation | Maintains: Sector Perform | $10 → $11 | $11.38 | -3.34% | 12 | Nov 7, 2025 | |
| PLRX Pliant Therapeutics | Maintains: Sector Perform | $3 → $2 | $1.20 | +66.67% | 14 | Nov 7, 2025 | |
| MNMD Mind Medicine (MindMed) | Maintains: Outperform | $21 → $20 | $12.41 | +61.16% | 10 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $28 → $32 | $31.73 | +0.85% | 13 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $137 → $145 | $220.38 | -34.20% | 2 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $34 → $32 | $26.27 | +21.81% | 3 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $58 | $44.21 | +31.19% | 20 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $423 → $415 | $456.47 | -9.08% | 56 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $30 → $19 | $5.93 | +220.40% | 13 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $60 → $70 | $75.75 | -7.59% | 2 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $100 → $105 | $123.22 | -14.79% | 33 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $217 → $210 | $180.95 | +16.05% | 41 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $704 → $708 | $721.63 | -1.89% | 34 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $156 → $160 | $152.37 | +5.01% | 23 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $81 → $84 | $100.16 | -16.13% | 24 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $67 → $10 | $14.80 | -32.43% | 3 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $70 | $66.43 | +5.37% | 1 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $25 → $23 | $22.61 | +1.75% | 35 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $13 | $8.02 | +62.09% | 19 | Jun 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $1.5 | $0.24 | +536.40% | 6 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $84 | $27.58 | +204.57% | 1 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $31 | $15.17 | +104.35% | 1 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $139 → $143 | $148.34 | -3.60% | 2 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $40 | $35.99 | +11.14% | 1 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $25 → $15 | $14.00 | +7.14% | 14 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $12 → $9 | $4.43 | +103.16% | 3 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $21 → $33 | $96.10 | -65.66% | 3 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $36.99 | - | 4 | Dec 4, 2017 |
Sionna Therapeutics
Dec 1, 2025
Downgrades: Underperform
Price Target: $24
Current: $41.11
Upside: -41.62%
PTC Therapeutics
Dec 1, 2025
Downgrades: Sector Perform
Price Target: $82 → $91
Current: $78.08
Upside: +16.55%
Neumora Therapeutics
Dec 1, 2025
Upgrades: Outperform
Price Target: $4 → $7
Current: $2.32
Upside: +201.72%
Contineum Therapeutics
Nov 21, 2025
Maintains: Outperform
Price Target: $25 → $22
Current: $11.29
Upside: +94.86%
Aardvark Therapeutics
Nov 14, 2025
Maintains: Outperform
Price Target: $19 → $18
Current: $12.33
Upside: +46.04%
Corbus Pharmaceuticals Holdings
Nov 13, 2025
Maintains: Outperform
Price Target: $55 → $53
Current: $10.63
Upside: +398.59%
aTyr Pharma
Nov 7, 2025
Maintains: Sector Perform
Price Target: $1.5 → $1
Current: $0.84
Upside: +19.16%
Prothena Corporation
Nov 7, 2025
Maintains: Sector Perform
Price Target: $10 → $11
Current: $11.38
Upside: -3.34%
Pliant Therapeutics
Nov 7, 2025
Maintains: Sector Perform
Price Target: $3 → $2
Current: $1.20
Upside: +66.67%
Mind Medicine (MindMed)
Nov 7, 2025
Maintains: Outperform
Price Target: $21 → $20
Current: $12.41
Upside: +61.16%
Nov 7, 2025
Maintains: Sector Perform
Price Target: $28 → $32
Current: $31.73
Upside: +0.85%
Nov 7, 2025
Maintains: Outperform
Price Target: $137 → $145
Current: $220.38
Upside: -34.20%
Nov 6, 2025
Maintains: Outperform
Price Target: $34 → $32
Current: $26.27
Upside: +21.81%
Nov 4, 2025
Maintains: Outperform
Price Target: $55 → $58
Current: $44.21
Upside: +31.19%
Nov 4, 2025
Maintains: Sector Perform
Price Target: $423 → $415
Current: $456.47
Upside: -9.08%
Nov 4, 2025
Maintains: Outperform
Price Target: $30 → $19
Current: $5.93
Upside: +220.40%
Nov 3, 2025
Maintains: Outperform
Price Target: $60 → $70
Current: $75.75
Upside: -7.59%
Oct 31, 2025
Maintains: Sector Perform
Price Target: $100 → $105
Current: $123.22
Upside: -14.79%
Oct 31, 2025
Maintains: Outperform
Price Target: $217 → $210
Current: $180.95
Upside: +16.05%
Oct 29, 2025
Maintains: Sector Perform
Price Target: $704 → $708
Current: $721.63
Upside: -1.89%
Oct 29, 2025
Maintains: Outperform
Price Target: $156 → $160
Current: $152.37
Upside: +5.01%
Oct 29, 2025
Maintains: Sector Perform
Price Target: $81 → $84
Current: $100.16
Upside: -16.13%
Sep 29, 2025
Downgrades: Sector Perform
Price Target: $67 → $10
Current: $14.80
Upside: -32.43%
Sep 16, 2025
Initiates: Outperform
Price Target: $70
Current: $66.43
Upside: +5.37%
Jul 17, 2025
Maintains: Sector Perform
Price Target: $25 → $23
Current: $22.61
Upside: +1.75%
Jun 30, 2025
Reiterates: Outperform
Price Target: $13
Current: $8.02
Upside: +62.09%
May 14, 2025
Reiterates: Sector Perform
Price Target: $1.5
Current: $0.24
Upside: +536.40%
Apr 22, 2025
Reiterates: Outperform
Price Target: $84
Current: $27.58
Upside: +204.57%
Mar 7, 2025
Initiates: Outperform
Price Target: $31
Current: $15.17
Upside: +104.35%
Feb 3, 2025
Maintains: Outperform
Price Target: $139 → $143
Current: $148.34
Upside: -3.60%
Jan 28, 2025
Reiterates: Outperform
Price Target: $40
Current: $35.99
Upside: +11.14%
Oct 2, 2023
Maintains: Sector Perform
Price Target: $25 → $15
Current: $14.00
Upside: +7.14%
Mar 31, 2022
Maintains: Sector Perform
Price Target: $12 → $9
Current: $4.43
Upside: +103.16%
Nov 3, 2021
Maintains: Sector Perform
Price Target: $21 → $33
Current: $96.10
Upside: -65.66%
Dec 4, 2017
Upgrades: Buy
Price Target: n/a
Current: $36.99
Upside: -